Variant report

Variant	rs10510755
Chromosome Location	chr3:50281168-50281169
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:23)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:23 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr3:50280717-50281445	GM12878	blood:	n/a	n/a
2	POLR2A	chr3:50280048-50281168	GM12892	blood:	n/a	n/a
3	ATF2	chr3:50280603-50281252	GM12878	blood:	n/a	n/a
4	RELA	chr3:50280248-50281239	GM18951	blood:	n/a	n/a
5	POLR2A	chr3:50280472-50281190	HUVEC	blood vessel:	n/a	n/a
6	POLR2A	chr3:50279757-50281289	HUVEC	blood vessel:	n/a	n/a
7	POLR2A	chr3:50281165-50281310	H1-hESC	embryonic stem cell:	n/a	n/a
8	RUNX3	chr3:50279828-50281275	GM12878	blood:	n/a	n/a
9	RCOR1	chr3:50280985-50281245	K562	blood:	n/a	n/a
10	RCOR1	chr3:50280588-50281464	IMR90	lung:	n/a	n/a
11	PML	chr3:50280032-50281252	GM12878	blood:	n/a	n/a
12	STAT5A	chr3:50280503-50281285	GM12878	blood:	n/a	n/a
13	RCOR1	chr3:50280993-50281268	K562	blood:	n/a	n/a
14	RUNX3	chr3:50279857-50281306	GM12878	blood:	n/a	n/a
15	POLR2A	chr3:50280104-50281397	GM12878	blood:	n/a	n/a
16	POLR2A	chr3:50279934-50281472	HUVEC	blood vessel:	n/a	n/a
17	POLR2A	chr3:50280061-50281285	HUVEC	blood vessel:	n/a	n/a
18	POLR2A	chr3:50280080-50281267	HL-60	blood:	n/a	n/a
19	POLR2A	chr3:50281100-50281310	HepG2	liver:	n/a	n/a
20	MTA3	chr3:50279623-50281483	GM12878	blood:	n/a	n/a
21	CHD2	chr3:50281123-50281236	GM12878	blood:	n/a	n/a
22	ATF2	chr3:50280803-50281224	GM12878	blood:	n/a	n/a
23	ZNF143	chr3:50281083-50281178	K562	blood:	n/a	n/a

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:50279236..50281282-chr3:50285946..50288178,2	MCF-7	breast:
2	chr3:50280753..50283616-chr3:50292547..50295659,3	K562	blood:
3	chr3:50280543..50283176-chr3:50335868..50337759,2	K562	blood:
4	chr3:50271160..50275227-chr3:50277363..50285143,16	MCF-7	breast:
5	chr3:50264006..50266516-chr3:50280953..50285850,5	K562	blood:
6	chr3:50280995..50282584-chr3:50289144..50291204,2	MCF-7	breast:

No data

Variant related genes	Relation type
GNAI2	TF binding region
ENSG00000186792	Chromatin interaction
ENSG00000114353	Chromatin interaction
ENSG00000243477	Chromatin interaction

Extended variants
information (count: 64 )
Associated
traits (count: 2 )

rSNPs within LD-proxies of this variant (count:36)

rs_ID	r²[population]
rs12629572	1.00[CEU][hapmap];0.90[GIH][hapmap];0.94[TSI][hapmap];0.83[EUR][1000 genomes]
rs12635953	0.93[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs1989839	1.00[CEU][hapmap];0.90[GIH][hapmap];0.87[TSI][hapmap]
rs2071802	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs2071803	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.87[TSI][hapmap];0.87[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2073498	1.00[ASW][hapmap];0.93[CEU][hapmap];1.00[CHB][hapmap];0.95[GIH][hapmap];1.00[JPT][hapmap];0.94[TSI][hapmap];0.85[AMR][1000 genomes];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2073499	0.93[CEU][hapmap]
rs2097247	0.96[AMR][1000 genomes];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2233474	0.93[CEU][hapmap]
rs2236939	0.86[CEU][hapmap];0.95[GIH][hapmap];0.94[TSI][hapmap];0.81[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs2236950	1.00[ASW][hapmap];0.80[GIH][hapmap]
rs2236967	1.00[ASW][hapmap]
rs2236968	1.00[ASW][hapmap]
rs2239801	1.00[CEU][hapmap];1.00[CHB][hapmap];0.88[EUR][1000 genomes]
rs2282756	1.00[ASW][hapmap]
rs2301639	1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.94[TSI][hapmap];0.87[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2526392	0.95[GIH][hapmap]
rs2526394	0.95[GIH][hapmap]
rs2526395	0.95[GIH][hapmap]
rs2526396	0.95[GIH][hapmap]
rs2624837	0.95[GIH][hapmap]
rs2624842	0.95[GIH][hapmap]
rs28365992	1.00[ASW][hapmap];1.00[CEU][hapmap];0.82[CHB][hapmap];0.95[GIH][hapmap];0.94[TSI][hapmap];0.85[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs3755832	1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs3806708	1.00[ASW][hapmap];1.00[CEU][hapmap];0.95[GIH][hapmap];1.00[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs41291724	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.83[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4141060	0.93[CEU][hapmap]
rs45536634	0.87[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs57319506	0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs57462170	0.84[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs57842657	0.81[AMR][1000 genomes];0.83[EUR][1000 genomes]
rs58051625	0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs60247651	0.86[AFR][1000 genomes];0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6776145	1.00[CEU][hapmap];0.90[GIH][hapmap];0.87[TSI][hapmap];0.81[EUR][1000 genomes]
rs762898	1.00[ASW][hapmap]
rs7642692	0.87[TSI][hapmap];0.81[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
2	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
3	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
4	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
5	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
6	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
7	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
8	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
9	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
10	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
11	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
12	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
13	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
14	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
15	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
16	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
17	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
19	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
20	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
21	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
22	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
23	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
24	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
25	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
26	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
27	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
28	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases

mRNA abundance (count:2)

SNP	Gene	Cis/trans	Tissue	Source
rs10510755	CYB561D2	cis	Liver	GTEx
rs10510755	CYB561D2	cis	multi-tissue	Pritchard

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50276000-50281200	Enhancers	H9 Cell Line	embryonic stem cell
2	chr3:50276000-50283000	Enhancers	Rectal Mucosa Donor 31	rectum
3	chr3:50276000-50283400	Enhancers	Stomach Mucosa	stomach
4	chr3:50276000-50283400	Genic enhancers	Spleen	Spleen
5	chr3:50276200-50281200	Enhancers	Fetal Heart	heart
6	chr3:50276200-50283200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr3:50276200-50283200	Genic enhancers	Fetal Adrenal Gland	Adrenal Gland
8	chr3:50276200-50283200	Genic enhancers	Fetal Stomach	stomach
9	chr3:50276200-50283200	Enhancers	Right Atrium	heart
10	chr3:50276200-50283400	Enhancers	Left Ventricle	heart
11	chr3:50276200-50286600	Genic enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr3:50276200-50287000	Genic enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
13	chr3:50276400-50283200	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
14	chr3:50276400-50283200	Genic enhancers	Fetal Muscle Trunk	muscle
15	chr3:50276400-50283200	Genic enhancers	Fetal Muscle Leg	muscle
16	chr3:50276400-50283200	Genic enhancers	Fetal Thymus	thymus
17	chr3:50276400-50283400	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
18	chr3:50276400-50283400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
19	chr3:50276400-50294400	Genic enhancers	Lung	lung
20	chr3:50276600-50283200	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr3:50276600-50283200	Genic enhancers	NHLF	lung
22	chr3:50276600-50283400	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr3:50276800-50281200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr3:50276800-50283200	Weak transcription	HepG2	liver
25	chr3:50276800-50283400	Weak transcription	Pancreatic Islets	Pancreatic Islet
26	chr3:50277000-50282800	Genic enhancers	Dnd41	blood
27	chr3:50277200-50283200	Enhancers	Primary T helper naive cells from peripheral blood	blood
28	chr3:50277400-50283200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
29	chr3:50277800-50281800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
30	chr3:50278000-50282400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
31	chr3:50278000-50283000	Enhancers	Right Ventricle	heart
32	chr3:50278000-50283400	Enhancers	Liver	Liver
33	chr3:50278400-50283200	Genic enhancers	NHEK	skin
34	chr3:50278600-50281200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr3:50278600-50283400	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr3:50278600-50287400	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr3:50278800-50281200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
38	chr3:50278800-50281200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
39	chr3:50278800-50281400	Flanking Active TSS	Primary B cells from cord blood	blood
40	chr3:50278800-50281400	Enhancers	Esophagus	oesophagus
41	chr3:50278800-50281600	Enhancers	Pancreas	Pancrea
42	chr3:50278800-50282400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
43	chr3:50278800-50286800	Enhancers	NHDF-Ad	bronchial
44	chr3:50279000-50282000	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr3:50279200-50281200	Enhancers	ES-I3 Cell Line	embryonic stem cell
46	chr3:50279200-50281400	Flanking Active TSS	Adipose Nuclei	Adipose
47	chr3:50279200-50283200	Weak transcription	Fetal Kidney	kidney
48	chr3:50279200-50283200	Weak transcription	Psoas Muscle	Psoas
49	chr3:50279400-50281200	Genic enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
50	chr3:50279400-50285000	Enhancers	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links